Shared on 18 Oct 25
Fair value Decreased 0.99%Valmet Oyj’s analyst price target has been slightly lowered from €28.74 to €28.46. Analysts point to steady but modest revisions in growth and margin forecasts supporting the update.
Shared on 03 Oct 25
Fair value Decreased 1.95%Analysts have adjusted their price target for Valmet Oyj slightly lower, to EUR 28.74 from EUR 29.31. This change reflects updated expectations for growth and profitability, despite recent positive rating actions.
Shared on 04 Sep 25
As neither the net profit margin nor the discount rate have materially changed, fundamental valuation drivers remain stable and, as a result, the consensus analyst price target for Valmet Oyj is unchanged at €29.31. What's in the News Valmet will deliver a complete IntelliTissue 1600 tissue machine and related systems to PT Suparma Tbk's Surabaya mill, adding 26,500 annual tons of production capacity, with start-up planned for 2026.
Shared on 23 Apr 25
Fair value Decreased 4.64%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 1.74%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 1.39%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Increased 5.15%AnalystConsensusTarget has increased revenue growth from 3.4% to 4.1%.